---
$id: https://graph.org.ai/products/commodity/51101937
$type: Product
source: UNSPSC
code: "51101937"
title: "Tafenoquine"
class: "51101900"
classTitle: "Antiprotozoals"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tafenoquine

**UNSPSC Code**: 51101937
**Class**: [Antiprotozoals](Antiprotozoals.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimalarial agent with the molecular formula C24H28F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 262P8GS9L9, chemically known as 1,4-pentanediamine, n4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)- but generally known as tafenoquine, which bears US NIH Compound Identifier 115358. European Medicines Agency schedules Tafenoquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04666MIG. The term TAFENOQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule tafenoquine under HS 29334990 and SITC 51575. As of Q4 2014, TAFENOQUINE remains the US FDA Preferred Term for this commodity. Tafenoquine bears US NLM identifiers UMLS ID C0903411 and NCI Concept Code C73006. SMILES: FC(F)(F)C1CC(OC2C3C(NC(OC)CC3C)C(NC(CCCN)C)CC2OC)CCC1.

